The TGA says it is continuing to discuss the adoption of a naming convention for biosimilars with other overseas regulators. The revelation comes following the release of a communiqué from the August meeting of the Biosimilar Awareness Initiative Reference Group, which was set up to “give guidance on the activities of the Biosimilar Awareness Initiative ...
Biosimilar naming convention undecided for now
By Nicola Garrett
22 Sep 2016